KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Tax ProvisionsTax Rate
Others
Ratios

BioNTech SE (BNTX) Other Operating Expenses (2021 - 2022)

Historic Other Operating Expenses for BioNTech SE (BNTX) over the last 3 years, with Q3 2025 value amounting to -$1.5 million.

  • BioNTech SE's Other Operating Expenses changed N/A to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year decrease of 91357567.58%. This contributed to the annual value of -$320578.6 for FY2024, which is 10784.08% down from last year.
  • Per BioNTech SE's latest filing, its Other Operating Expenses stood at -$1.5 million for Q3 2025.
  • BioNTech SE's Other Operating Expenses' 5-year high stood at $3.6 million during Q3 2023, with a 5-year trough of -$1.5 million in Q3 2025.
  • For the 3-year period, BioNTech SE's Other Operating Expenses averaged around $281318.8, with its median value being -$105188.4 (2025).
  • Data for BioNTech SE's Other Operating Expenses shows a peak YoY increase of 14965.87% (in 2024) and a maximum YoY decrease of 29778.93% (in 2024) over the last 5 years.
  • Quarter analysis of 3 years shows BioNTech SE's Other Operating Expenses stood at $215188.0 in 2023, then crashed by 149.66% to -$106859.5 in 2024, then plummeted by 1322.21% to -$1.5 million in 2025.
  • Its last three reported values are -$1.5 million in Q3 2025, -$105188.4 for Q1 2025, and -$106859.5 during Q4 2024.